Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NavJam is a medical technology company focused on developing accessible and cost-effective spinal navigation solutions. The company's primary offering is the NavJam Jamshidi, a disposable, wireless device that provides surgeons with real-time trajectory and orientation feedback during pedicle screw placement. By eliminating the need for expensive capital equipment and specialized staff, NavJam's platform serves as a practical alternative to traditional, multi-million dollar navigation systems. The technology is designed to integrate seamlessly with the RJB intraoperative measurement system to improve surgical accuracy while reducing radiation exposure and procedure time. NavJam maintains a global presence through a strategic distribution partnership with Ruthless Spine, enabling its use in both well-funded medical centers and resource-limited environments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NavJam.